{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:03:52Z","timestamp":1778601832361,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,26]],"date-time":"2027-01-26T00:00:00Z","timestamp":1800921600000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY035088"],"award-info":[{"award-number":["R01EY035088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY023295"],"award-info":[{"award-number":["R01EY023295"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemical Engineering Journal"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cej.2026.173145","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:27:05Z","timestamp":1768807625000},"page":"173145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["NeuProIO: A dual-action solid drug nanoparticle topical formulation for simultaneous intraocular pressure reduction and neuroprotection for glaucoma"],"prefix":"10.1016","volume":"530","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimalin Jeyalatha","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruipu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cej.2026.173145_bb0005","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"issue":"10414","key":"10.1016\/j.cej.2026.173145_bb0010","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","article-title":"Glaucoma: now and beyond","volume":"402","author":"Jayaram","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0015","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajo.2011.03.005","article-title":"Intraocular pressure, central corneal thickness, and glaucoma in Chinese adults: the Liwan Eye Study","volume":"152","author":"Wang","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.cej.2026.173145_bb0020","first-page":"1","article-title":"Should poor sleep be added to the list of risk factors for normal-tension glaucoma in the future?","author":"Wostyn","year":"2025","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","article-title":"Oxidative stress and mitochondrial dysfunction in glaucoma","volume":"13","author":"Chrysostomou","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6","key":"10.1016\/j.cej.2026.173145_bb0030","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","article-title":"Critical pathogenic events underlying progression of neurodegeneration in glaucoma","volume":"31","author":"Calkins","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.cej.2026.173145_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in glaucoma: from the back to the front of the eye, and beyond","volume":"83","author":"Baudouin","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.cej.2026.173145_bb0040","article-title":"Topical medication therapy for glaucoma and ocular hypertension","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.cej.2026.173145_bb0045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3390\/ph17091190","article-title":"Neuroprotective nanocarriers in glaucoma","volume":"17","author":"Pei","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cej.2026.173145_bb0050","article-title":"Addressing neurodegeneration in glaucoma: mechanisms, challenges, and treatments","volume":"100","author":"Ghanem","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13812","article-title":"Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model","volume":"9","author":"Tsuruga","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.cej.2026.173145_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.705405","article-title":"Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage","volume":"12","author":"Conti","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.cej.2026.173145_bb0065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archopht.120.6.797","article-title":"Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells","volume":"120","author":"Gao","year":"2002","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.cej.2026.173145_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.cej.2026.173145_bb0075","first-page":"390","article-title":"Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma","volume":"18","author":"Cybulska-Heinrich","year":"2012","journal-title":"Mol. Vis."},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.cej.2026.173145_bb0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2174\/1570159X15666170705101910","article-title":"Strategies to reduce oxidative stress in glaucoma patients","volume":"16","author":"Pinazo-Duran","year":"2018","journal-title":"Curr. Neuropharmacol."},{"issue":"1\u20132","key":"10.1016\/j.cej.2026.173145_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2004.01.078","article-title":"Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat","volume":"1007","author":"Candelario-Jalil","year":"2004","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.cej.2026.173145_bb0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/antiox9111031","article-title":"Glaucoma and antioxidants: review and update","volume":"9","author":"Garcia-Medina","year":"2020","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0100","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1038\/s41467-022-34682-y","article-title":"Maprotiline restores ER homeostasis and rescues neurodegeneration via histamine receptor H1 inhibition in retinal ganglion cells","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.cej.2026.173145_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","article-title":"On the use of the Weibull function for the discernment of drug release mechanisms","volume":"309","author":"Papadopoulou","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cej.2026.173145_bb0110","first-page":"125","article-title":"Mathematical modeling of drug release from swellable polymeric nanoparticles, journal of applied pharmaceutical","volume":"7","author":"Azadi","year":"2017","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.cej.2026.173145_bb0115","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3390\/polym13172897","article-title":"Weibull modeling of controlled drug release from ag-PMA nanosystems","volume":"13","author":"Corsaro","year":"2021","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0120","first-page":"217","article-title":"Kinetic modeling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"9","key":"10.1016\/j.cej.2026.173145_bb0125","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/nn301873v","article-title":"Hybrid dendrimer hydrogel\/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration","volume":"6","author":"Yang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.cej.2026.173145_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11095-014-1461-9","article-title":"Semi-interpenetrating network (sIPN) co-electrospun gelatin\/insulin fiber formulation for transbuccal insulin delivery","volume":"32","author":"Xu","year":"2015","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.cej.2026.173145_bb0135","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/cn200078m","article-title":"Transbuccal delivery of CNS therapeutic nanoparticles: synthesis, characterization, and in vitro permeation studies","volume":"2","author":"Yuan","year":"2011","journal-title":"ACS Chem. Nerosci."},{"issue":"10","key":"10.1016\/j.cej.2026.173145_bb0140","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/03639040500306203","article-title":"Preparation and evaluation of sustained ophthalmic gel of enoxacin","volume":"31","author":"Liu","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.cej.2026.173145_bb0145","series-title":"StatPearls [Internet]","article-title":"Betaxolol","author":"Tajran","year":"2024"},{"key":"10.1016\/j.cej.2026.173145_bb0150","series-title":"96: Hen\u2019s Egg Test on the Chorioallantoic Membrane (HET-CAM), EURL ECVAM DB-ALM: Protocol","author":"Ecvam","year":"2007"},{"key":"10.1016\/j.cej.2026.173145_bb0155","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45881","article-title":"Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse","volume":"8","author":"Zhang","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.cej.2026.173145_bb0160","article-title":"A reversible silicon oil-induced ocular hypertension model in mice","volume":"153","author":"Zhang","year":"2019","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0165","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1038\/s41598-021-88690-x","article-title":"Chronic mild and acute severe glaucomatous neurodegeneration derived from silicone oil-induced ocular hypertension","volume":"11","author":"Fang","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.cej.2026.173145_bb0170","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/antibiotics12091405","article-title":"Lyophilized lipid liquid crystalline nanoparticles as an antimicrobial delivery system","volume":"12","author":"Awad","year":"2023","journal-title":"Antibiotics"},{"issue":"17","key":"10.1016\/j.cej.2026.173145_bb0175","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.3390\/ijms23179657","article-title":"The effect of trehalose coating for magnetite nanoparticles on stability of egg white lysozyme","volume":"23","author":"Lajmorak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cej.2026.173145_bb0180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10973-014-4275-4","article-title":"Effect of cryoprotectants on the reconstitution of silica nanoparticles produced by sol\u2013gel technology","volume":"120","author":"Andreani","year":"2015","journal-title":"J. Therm. Anal. Calorim."},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/02652048.2018.1462416","article-title":"Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers","volume":"35","author":"Wang","year":"2018","journal-title":"J. Microencapsul."},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0190","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1038\/ncomms3653","article-title":"Flash freezing route to mesoporous polymer nanofibre networks","volume":"4","author":"Samitsu","year":"2013","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.cej.2026.173145_bb0195","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cej.2026.173145_bb0200","first-page":"1921","article-title":"Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation","author":"Dai","year":"2013","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/prot.10632","article-title":"Trehalose\u2013protein interaction in aqueous solution","volume":"55","author":"Lins","year":"2004","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"10.1016\/j.cej.2026.173145_bb0210","series-title":"Biological Functions of Trehalose as a Substitute for Water, Water and Biomolecules: Physical Chemistry of Life Phenomena","first-page":"219","author":"Sakurai","year":"2009"},{"issue":"1\u20132","key":"10.1016\/j.cej.2026.173145_bb0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.cej.2026.173145_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/tcrm.2006.2.2.193","article-title":"The management of glaucoma and intraocular hypertension: current approaches and recent advances","volume":"2","author":"Noecker","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"issue":"6","key":"10.1016\/j.cej.2026.173145_bb0225","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"M.A. Kass, D.K. Heuer, E.J. Higginbotham, C.A. Johnson, J.L. Keltner, J.P. Miller, R.K. Parrish, M.R. Wilson, M.O. Gordon, O.H.T.S. Group","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.cej.2026.173145_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.crimmu.2023.100073","article-title":"Nanoparticles cellular uptake, trafficking, activation, toxicity and in vitro evaluation","volume":"4","author":"Toscano","year":"2023","journal-title":"Curr. Res. Immunol."},{"key":"10.1016\/j.cej.2026.173145_bb0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jconrel.2022.03.012","article-title":"Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes","volume":"345","author":"McGuckin","year":"2022","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.cej.2026.173145_bb0240","first-page":"1338","article-title":"Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs","volume":"1","author":"Tiwari","year":"2009","journal-title":"Int. J. PharmTech Res."},{"issue":"9","key":"10.1016\/j.cej.2026.173145_bb0245","article-title":"Microfluidics for production of particles: mechanism, methodology, and applications","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.cej.2026.173145_bb0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nantod.2016.04.006","article-title":"Principles of nanoparticle formation by flash nanoprecipitation","volume":"11","author":"Saad","year":"2016","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.cej.2026.173145_bb0255","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/acsmaterialslett.0c00078","article-title":"Different strategies for organic nanoparticle preparation in biomedicine","volume":"2","author":"Fang","year":"2020","journal-title":"ACS Mater. Lett."},{"issue":"5","key":"10.1016\/j.cej.2026.173145_bb0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41563-020-0672-1","article-title":"Active transcytosis and new opportunities for cancer nanomedicine","volume":"19","author":"Pandit","year":"2020","journal-title":"Nat. Mater."},{"issue":"20","key":"10.1016\/j.cej.2026.173145_bb0265","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1039\/D1TB00229E","article-title":"Bioadhesive glycosylated nanoformulations for extended trans-corneal drug delivery to suppress corneal neovascularization","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.cej.2026.173145_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cej.2026.173145_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00745-9","article-title":"Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy","volume":"19","author":"Swetledge","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40123-020-00257-7","article-title":"Therapies based on nanoparticles for eye drug delivery","volume":"9","author":"Meza-Rios","year":"2020","journal-title":"Ophthalmol Therapy"},{"issue":"3","key":"10.1016\/j.cej.2026.173145_bb0285","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cej.2026.173145_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120380","article-title":"Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma","volume":"598","author":"Allam","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.preteyeres.2009.08.002","article-title":"Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?\u2013an exemplary analysis on the basis of two beta-blockers","volume":"29","author":"Grieshaber","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.cej.2026.173145_bb0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0420.1998.760108.x","article-title":"The acute effect of topical beta-adrenoreceptor blocking agents on retinal and optic nerve head circulation","volume":"76","author":"Arend","year":"1998","journal-title":"Acta Ophthalmol. Scand."},{"issue":"2","key":"10.1016\/j.cej.2026.173145_bb0305","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9394(14)72604-2","article-title":"Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma","volume":"120","author":"Harris","year":"1995","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.cej.2026.173145_bb0310","first-page":"1071","article-title":"Are there any benefits of Betoptic\u00ae S (betaxolol HCl ophthalmic suspension) over other \u03b2-blockers in the treatment of glaucoma?","volume":"5","author":"Yarang\u00fcmeli","year":"2004","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Chemical Engineering Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1385894726006042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1385894726006042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:14:45Z","timestamp":1774487685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1385894726006042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":62,"alternative-id":["S1385894726006042"],"URL":"https:\/\/doi.org\/10.1016\/j.cej.2026.173145","relation":{},"ISSN":["1385-8947"],"issn-type":[{"value":"1385-8947","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NeuProIO: A dual-action solid drug nanoparticle topical formulation for simultaneous intraocular pressure reduction and neuroprotection for glaucoma","name":"articletitle","label":"Article Title"},{"value":"Chemical Engineering Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cej.2026.173145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"173145"}}